ContributorsPublishersAdvertisers

Takeda broadens gene therapy scope, turns to Poseida for non-viral approach

MedCity News
 2021-10-12

Cover picture for the articleTakeda Pharmaceutical already has gene therapy prospects, but it wants a piece of this market in a way that avoids the safety risks from the engineered viruses that deliver these treatments to their destinations in the body. Poseida Therapeutics has several non-viral gene therapy technologies, and Takeda is putting up some...

medcitynews.com

Comments / 0

Comments / 0